RxDoctor Payments DataLook up a doctor →

Jordan Safirstein, MD

Cardiovascular Disease · Mountain Lakes, NJNPI 1922265495

Payments from drug & device makers

$291,636in general payments, 2019–2025

Across 767 payments — averaging $380.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Cathworks, Inc.$120K
  • Biolife, L.L.C.$50K
  • M.a. Med Alliance S.A.$38K
  • Spectrawave, Inc$22K
  • Cardiovascular Systems Inc.$15K
  • Medtronic$11K
  • plus $36K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Cathworks, Inc.16$120,122
Biolife, L.L.C.6$50,399
M.a. Med Alliance S.A.12$38,179
Spectrawave, Inc5$21,605
Cardiovascular Systems Inc.35$15,164
Medtronic(2 entities)49$10,556
Shockwave Medical, Inc16$8,967
Abbott41$5,479
Boston Scientific41$4,636
Edwards Lifesciences146$4,336
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)10$4,177
Novartis66$778
Abiomed9$672
Amgen36$557
Pfizer39$528
Terumo Medical Corporation3$389
Merck24$374
Sanofi-aventis U.S. LLC25$368
AstraZeneca20$358
Teleflex LLC2$289
Amarin Pharma, Inc.18$250
E.r. Squibb & Sons, L.L.C.14$206
Johnson & Johnson13$197
Opsens Inc.4$171
Irhythm Technologies, Inc.9$169
Novo Nordisk9$164
Boehringer Ingelheim10$161
Chiesi USA, Inc.5$152
Bayer7$145
Acist Medical Systems, Inc.1$132
Cordis US CORP.2$130
Saranas, Inc.2$120
Stryker1$110
Angiodynamics, Inc.2$106
Esperion Therapeutics, Inc.7$102
Asahi Intecc USA, Inc.1$98
Philips North America LLC2$97
Inari Medical, Inc.1$89
Baxter Healthcare2$84
Regeneron Healthcare Solutions, Inc.5$77
Heartflow, Inc.4$77
Cardiva Medical, Inc.1$68
Kiniksa Pharmaceuticals International, PLC4$64
Kowa Pharmaceuticals America, Inc.4$55
Atricure, Inc.2$53
Lexicon Pharmaceuticals, Inc.3$52
Kestra Medical Technology Services, Inc.3$50
W. L. Gore & Associates, Inc.3$49
Actelion Pharmaceuticals US, Inc.3$48
Cvrx, Inc.2$43
Arbor Pharmaceuticals, Inc.3$38
Scpharmaceuticals Inc.2$36
Althera Pharmaceuticals LLC2$34
GSK2$34
Biosense Webster, Inc.1$34
Azurity Pharmaceuticals, Inc.2$31
Lundbeck LLC2$28
Surmodics, Inc.1$28
Impulse Dynamics (USA) Inc.1$26
Recor Medical Inc1$20

How this compares

$291,636 in reported general payments places this provider in the 95th percentile of 1,006 cardiovascular disease providers in New Jersey.

See all cardiovascular disease providers in New Jersey →

Medicare billing

Part B allowed, 2024
$422,883
Medicare patients
1,149
Services billed
3,817

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other cardiovascular disease in Mountain Lakes

See the full list for New Jersey →

Where these figures come from

Is this you, or does something look wrong? →